Marker Therapeutics Inc (MRKR)

[4fatcat4]

I agree, it's something I can't even contemplate being considered.

That being said, what will pharma companies think of the data? I realize everything being said about the timing and presentation of the results of the trials and the effects on the pps, but what will the companies that base their evaluations on the data itself think about what MRKR offers? Doesn't seem reasonable to me that they would ignore the critical benefits of this treatment, and the fact that moving forward it could be tweaked to be even more effective with no side effects that haunts chemo treatments.